Isracann Biosciences Stock Price Prediction
As of 1st of December 2024 the relative strength index (rsi) of Isracann Biosciences' share price is below 20 . This usually indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Isracann Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Isracann Biosciences and does not consider all of the tangible or intangible factors available from Isracann Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Isracann Biosciences, which may create opportunities for some arbitrage if properly timed.
Check out Isracann Biosciences Basic Forecasting Models to cross-verify your projections.
Oversold Vs Overbought
0
Oversold | Overbought |
Using Isracann Biosciences hype-based prediction, you can estimate the value of Isracann Biosciences from the perspective of Isracann Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Isracann Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Isracann because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Isracann Biosciences after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Isracann |
Isracann Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Isracann Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Isracann Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Isracann Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Isracann Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Isracann Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Isracann Biosciences' historical news coverage. Isracann Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 12.60, respectively. We have considered Isracann Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Isracann Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Isracann Biosciences is based on 3 months time horizon.
Isracann Biosciences Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Isracann Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Isracann Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Isracann Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.59 | 12.60 | 0.00 | 0.63 | 0 Events / Month | 5 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
Isracann Biosciences Hype Timeline
Isracann Biosciences is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.63. Isracann is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -1.59%. %. The volatility of related hype on Isracann Biosciences is about 3185.39%, with the expected price after the next announcement by competition of -0.63. The company recorded a loss per share of 0.13. Isracann Biosciences last dividend was issued on the 17th of October 2019. The entity had 1:3 split on the 17th of October 2019. Assuming the 90 days horizon the next estimated press release will be uncertain. Check out Isracann Biosciences Basic Forecasting Models to cross-verify your projections.Isracann Biosciences Related Hype Analysis
Having access to credible news sources related to Isracann Biosciences' direct competition is more important than ever and may enhance your ability to predict Isracann Biosciences' future price movements. Getting to know how Isracann Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Isracann Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HENC | Holloman Energy Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| YCBD | cbdMD Inc | 0.06 | 2 per month | 3.69 | (0.03) | 6.82 | (7.41) | 28.60 | |
| EOLS | Evolus Inc | (0.97) | 10 per month | 0.00 | (0.09) | 5.06 | (4.70) | 22.78 | |
| CVSI | CV Sciences | 0.00 | 0 per month | 6.71 | (0) | 25.00 | (20.00) | 45.00 | |
| AKAN | Akanda Corp | (0.06) | 2 per month | 0.00 | (0.10) | 8.00 | (6.67) | 22.55 | |
| BFRI | Biofrontera | (0.06) | 6 per month | 7.25 | 0 | 14.63 | (11.70) | 46.72 | |
| COLL | Collegium Pharmaceutical | (0.86) | 8 per month | 0.00 | (0.17) | 3.23 | (4.47) | 12.29 | |
| ANIP | ANI Pharmaceuticals | (1.53) | 11 per month | 0.00 | (0.10) | 3.70 | (3.75) | 10.82 | |
| INCR | INC Research Holdings | (0.14) | 8 per month | 0.00 | (0.19) | 5.79 | (6.88) | 29.33 |
Isracann Biosciences Additional Predictive Modules
Most predictive techniques to examine Isracann price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Isracann using various technical indicators. When you analyze Isracann charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Isracann Biosciences Predictive Indicators
The successful prediction of Isracann Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Isracann Biosciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Isracann Biosciences based on analysis of Isracann Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Isracann Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Isracann Biosciences's related companies.
Story Coverage note for Isracann Biosciences
The number of cover stories for Isracann Biosciences depends on current market conditions and Isracann Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Isracann Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Isracann Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Isracann Biosciences Short Properties
Isracann Biosciences' future price predictability will typically decrease when Isracann Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Isracann Biosciences often depends not only on the future outlook of the potential Isracann Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Isracann Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 158.3 M |
Complementary Tools for Isracann Pink Sheet analysis
When running Isracann Biosciences' price analysis, check to measure Isracann Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isracann Biosciences is operating at the current time. Most of Isracann Biosciences' value examination focuses on studying past and present price action to predict the probability of Isracann Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isracann Biosciences' price. Additionally, you may evaluate how the addition of Isracann Biosciences to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |